Studies have revealed that among these cytokines, the IL-17 family (IL-17A to IL-17 F) and their receptor (IL-17RA to IL-17RE) are involved in Th17 responses, and they can participate in pro-tumor or anti-tumor responses depending on their phenotype [13]. The gene discussed is IL17A; the disease is neoplasm.